30 results on '"Peulen H"'
Search Results
2. OC-0269 Early toxicity of SBRT for oligometastatic cancer patients in the EORTC/ESTRO OligoCare cohort
3. OC-0270 Metastases-directed SRT and systemic therapy: EORTC-ESTRO OligoCare delphi consensus recommendations
4. OC-0611 Lungtech EORTC 22113-08113 prospective multicenter trial: SBRT for central lung tumors.
5. PD-0887 Quality assurance of delineation for locally recurrent rectal cancer: PelvEx II data (NCT04389086)
6. Neoadjuvant FOLFOXIRI prior to chemoradiotherapy for high-risk (“ugly”) locally advanced rectal cancer: study protocol of a single-arm, multicentre, open-label, phase II trial (MEND-IT)
7. OC-0599 Factors associated with SBRT doses in oligometastatic disease: an EORTC/ESTRO OligoCare analysis
8. PO-1323 Narrowing the difference in dose delivery for IOERT and IOBT for rectal cancer
9. OC-0267 Comprising a consensus-based delineation guideline for locally recurrent rectal cancer
10. PD-0740 Real-world patient & treatment characteristics of oligometastatic disease: results of OligoCare
11. Curative treatment of locally recurrent rectal cancer: is induction chemotherapy warranted?
12. Improved Outcomes for Responders After Treatment with Induction Chemotherapy and Chemo(re)irradiation for Locally Recurrent Rectal Cancer
13. Study protocols of three parallel phase 1 trials combining radical radiotherapy with the PARP inhibitor olaparib
14. OC-0061 EORTC 22113-8113 Lungtech trial on SBRT of central lung tumors
15. EP-2209: Results of a multicentre dosimetry audit using a respiratory phantom within the EORTC Lungtech trial
16. PO-0967: Quality assurance of 4DCT in the EORTC Lungtech trial on SBRT for patients with NSCLC
17. PV-0042: SBRT for peripheral lung tumors >5 cm: first results of the multicenter phase I/II VOLUMES trial
18. MA 13.09 Toxicity and Second Primary Lung Cancers in Late Survivors Following Lung SBRT
19. EP-1838: First IGRT results for SBRT bone and lymph node oligometastases within the pelvic region
20. PV-0277: SBRT with concurrent chemoradiation in stage III NSCLC: first results of the phase I Hybrid trial
21. 99PD: Modelling of pulmonary function test changes after stereotactic body radiotherapy for stage I NSCLC
22. OC-0399: Dose to heart substructures is associated with non-cancer death after SBRT in stage I NSCLC patients
23. Stereotactic body radiotherapy for central lung tumours:Author reply
24. LungTech, an EORTC Phase II trial of stereotactic body radiotherapy for centrally located lung tumours: a clinical perspective
25. PD-0050: Predictors and patterns of regional recurrence following lung SBRT: A report from the Elekta Lung Research Group
26. Outcome After Sbrt for Potentially Operable Nsclc Patients
27. PO-0907: TCP modeling in a large cohort of NSCLC patients inclusive of geometric uncertainties
28. PD-0280: Clinical implementation of hybrid-lung radiotherapy with combined stereotactic and conventional fractionation
29. PO-0903 DOSE RESPONSE ANALYSIS OF RADIATION INDUCED RIB FRACTURES AFTER SBRT FOR NSCLC
30. Complete metabolic remission of an irresectable mediastinal solitary fibrous tumour with concurrent chemoradiation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.